KB

Kottakunnel Biju

Active Director Whole-Time Director DIN 09568452
DIN 09568452 First appointment Apr 2022 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Kottakunnel Biju

Data last updated:

Kottakunnel Biju is a Whole-Time Director at Remedia Sante Pharmaceuticals Private Limited (since 2022). The company operates in Home Appliances.

DIN 09568452
Primary Designation Whole-Time Director
Industry Home Appliances
First Appointment 11 Apr 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director11 Apr 20222022Active

Board colleagues of Kottakunnel Biju

Directorship timeline

Open interactive timeline →
Remedia Sante Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kottakunnel Biju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kottakunnel Biju

Kottakunnel Biju currently holds 1 directorship: Remedia Sante Pharmaceuticals Private Limited (Whole-Time Director, since 11 Apr 2022).

Kottakunnel Biju was first appointed on 11 Apr 2022 as Whole-Time Director at Remedia Sante Pharmaceuticals Private Limited.

The current boards of Kottakunnel Biju's companies include Asish Thachambalath (Remedia Sante Pharmaceuticals Private Limited), Sanath Kumar (Remedia Sante Pharmaceuticals Private Limited), Shaini (Remedia Sante Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available